118 related articles for article (PubMed ID: 19958795)
21. [Screening peptides binding specifically to large intestinal cancer LoVo cells from phage random peptide library].
Liao KX; Yao XQ; Wu CT; Lin F; Wu WL; Zeng SD; Luo YQ; Lei ST
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):986-90. PubMed ID: 18583245
[TBL] [Abstract][Full Text] [Related]
22. Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection.
Yao VJ; Ozawa MG; Trepel M; Arap W; McDonald DM; Pasqualini R
Am J Pathol; 2005 Feb; 166(2):625-36. PubMed ID: 15681844
[TBL] [Abstract][Full Text] [Related]
23. [Screening of short peptides that bind specifically to osteosarcoma cells by phage-displayed peptide library].
Zhu GH; Liu BY; Zheng SG; Lü H; Shi ZJ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan; 23(1):12-5. PubMed ID: 12527505
[TBL] [Abstract][Full Text] [Related]
24. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library.
Zang L; Shi L; Guo J; Pan Q; Wu W; Pan X; Wang J
Cancer Lett; 2009 Aug; 281(1):64-70. PubMed ID: 19327883
[TBL] [Abstract][Full Text] [Related]
25. On the synergistic effects of ligand-mediated and phage-intrinsic properties during in vivo selection.
Driessen WH; Bronk LF; Edwards JK; Proneth B; Souza GR; Decuzzi P; Pasqualini R; Arap W
Adv Genet; 2010; 69():115-33. PubMed ID: 20807605
[TBL] [Abstract][Full Text] [Related]
26. Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands.
Ardelt PU; Wood CG; Chen L; Mintz PJ; Moya C; Arap MA; Wright KC; Pasqualini R; Arap W
J Urol; 2003 Apr; 169(4):1535-40. PubMed ID: 12629410
[TBL] [Abstract][Full Text] [Related]
27. Molecular addresses of tumors: selection by in vivo phage display.
Li XB; Schluesener HJ; Xu SQ
Arch Immunol Ther Exp (Warsz); 2006; 54(3):177-81. PubMed ID: 16736105
[TBL] [Abstract][Full Text] [Related]
28. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride.
Müller G; Korndörfer A; Kornak U; Malaisse WJ
Arch Biochem Biophys; 1994 Jan; 308(1):8-23. PubMed ID: 8311478
[TBL] [Abstract][Full Text] [Related]
29. Tech.Sight. Phage display. Affinity selection from biological libraries.
Smothers JF; Henikoff S; Carter P
Science; 2002 Oct; 298(5593):621-2. PubMed ID: 12386335
[TBL] [Abstract][Full Text] [Related]
30. Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides.
Trepel M; Pasqualini R; Arap W
Methods Enzymol; 2008; 445():83-106. PubMed ID: 19022056
[TBL] [Abstract][Full Text] [Related]
31. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion.
Romanov VI; Durand DB; Petrenko VA
Prostate; 2001 Jun; 47(4):239-51. PubMed ID: 11398171
[TBL] [Abstract][Full Text] [Related]
32. Screening of peptide-displaying phage libraries to identify short peptides mimicking carbohydrates.
Fukuda MN
Methods Enzymol; 2006; 416():51-60. PubMed ID: 17113859
[TBL] [Abstract][Full Text] [Related]
33. Effect of islet cell surface antibodies on neonatal rat pancreatic islet cells or isolated islets of Langerhans in vitro.
Schröder D; Hehmke B; Kohnert KD; Fiebach H; Jenssen HL; Besch W
Biomed Biochim Acta; 1985; 44(1):107-15. PubMed ID: 3888202
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
McQuade P; Knight LC; Welch MJ
Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
[TBL] [Abstract][Full Text] [Related]
35. [Selection of the peptides specifically binding to hepatoma by using phage display in vivo].
Du B; Yu J; Zhou ZL; Zhang P; Yu M; Qian M
Zhonghua Zhong Liu Za Zhi; 2005 Nov; 27(11):645-7. PubMed ID: 16438882
[TBL] [Abstract][Full Text] [Related]
36. Identification of cancer targets and therapeutics using phage display.
Brissette R; Prendergast JK; Goldstein NI
Curr Opin Drug Discov Devel; 2006 May; 9(3):363-9. PubMed ID: 16729733
[TBL] [Abstract][Full Text] [Related]
37. The survival identification of pancreatic islets of Langerhans. In vitro and in vivo effects of two dithizone preparations on staining of rat and human islets of Langerhans-preliminary study (Part I).
Fiedor P; Rowiński W; Licińska I; Mazurek AP; Hardy MA
Acta Pol Pharm; 1995; 52(5):431-6. PubMed ID: 8960276
[TBL] [Abstract][Full Text] [Related]
38. Phage display technology for stem cell delivery and systemic therapy.
Staquicini FI; Sidman RL; Arap W; Pasqualini R
Adv Drug Deliv Rev; 2010 Sep; 62(12):1213-6. PubMed ID: 20932865
[TBL] [Abstract][Full Text] [Related]
39. Peptide-mediated targeting of the islets of Langerhans.
Samli KN; McGuire MJ; Newgard CB; Johnston SA; Brown KC
Diabetes; 2005 Jul; 54(7):2103-8. PubMed ID: 15983211
[TBL] [Abstract][Full Text] [Related]
40. Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis.
Joyce JA; Laakkonen P; Bernasconi M; Bergers G; Ruoslahti E; Hanahan D
Cancer Cell; 2003 Nov; 4(5):393-403. PubMed ID: 14667506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
